Conmed (CNMD) Other Accumulated Expenses (2010 - 2026)

Conmed (CNMD) has reported Other Accumulated Expenses for 17 consecutive years, with $106.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Accumulated Expenses fell 14.67% year-over-year to $106.8 million; the trailing twelve-month figure through Jun 2026 stood at $106.8 million (down 14.67% YoY), and the FY2025 full-year result was $138.5 million, up 26.18% from the prior year.
• Other Accumulated Expenses declined to $106.8 million in Q2 2026 per CNMD's latest filing, from $125.7 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $163.5 million in Q3 2023 and bottomed at $62.5 million in Q1 2022.
• Historically, Other Accumulated Expenses has averaged $118.7 million across 5 years, with a median of $125.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses soared 104.31% in 2023, then declined 29.29% in 2024.
• Over 5 years, Other Accumulated Expenses stood at $98.7 million in 2022, then jumped by 53.76% to $151.7 million in 2023, then slipped by 27.63% to $109.8 million in 2024, then advanced by 26.18% to $138.5 million in 2025, then dropped by 22.94% to $106.8 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $106.8 million, $125.7 million, and $138.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.